Harvard Bioscience Stock Technical Analysis

HBIO Stock  USD 0.60  0.07  13.21%   
As of the 10th of February, Harvard Bioscience retains the Downside Deviation of 4.81, market risk adjusted performance of 0.0735, and Risk Adjusted Performance of 0.0336. Harvard Bioscience technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Harvard Bioscience Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Harvard, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HarvardHarvard Bioscience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Harvard Bioscience 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Harvard Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Harvard Bioscience.
0.00
11/12/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/10/2026
0.00
If you would invest  0.00  in Harvard Bioscience on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Harvard Bioscience or generate 0.0% return on investment in Harvard Bioscience over 90 days. Harvard Bioscience is related to or competes with Nexgel, Retractable Technologies, Femasys, Nexalin Technology, TAO Synergies, NuCana PLC, and Cosmos Health. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental... More

Harvard Bioscience Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Harvard Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Harvard Bioscience upside and downside potential and time the market with a certain degree of confidence.

Harvard Bioscience Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Harvard Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Harvard Bioscience's standard deviation. In reality, there are many statistical measures that can use Harvard Bioscience historical prices to predict the future Harvard Bioscience's volatility.
Hype
Prediction
LowEstimatedHigh
0.030.616.69
Details
Intrinsic
Valuation
LowRealHigh
0.050.937.01
Details

Harvard Bioscience February 10, 2026 Technical Indicators

Harvard Bioscience Backtested Returns

As of now, Harvard Stock is abnormally volatile. Harvard Bioscience holds Efficiency (Sharpe) Ratio of 0.0312, which attests that the entity had a 0.0312 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Harvard Bioscience, which you can use to evaluate the volatility of the firm. Please check out Harvard Bioscience's Market Risk Adjusted Performance of 0.0735, downside deviation of 4.81, and Risk Adjusted Performance of 0.0336 to validate if the risk estimate we provide is consistent with the expected return of 0.19%. Harvard Bioscience has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 2.83, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harvard Bioscience will likely underperform. Harvard Bioscience right now retains a risk of 6.08%. Please check out Harvard Bioscience value at risk, as well as the relationship between the skewness and day median price , to decide if Harvard Bioscience will be following its current trending patterns.

Auto-correlation

    
  -0.71  

Almost perfect reverse predictability

Harvard Bioscience has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Harvard Bioscience time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Harvard Bioscience price movement. The serial correlation of -0.71 indicates that around 71.0% of current Harvard Bioscience price fluctuation can be explain by its past prices.
Correlation Coefficient-0.71
Spearman Rank Test-0.53
Residual Average0.0
Price Variance0.0
Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Harvard Bioscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Harvard Bioscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Harvard Bioscience Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Harvard Bioscience across different markets.

About Harvard Bioscience Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Harvard Bioscience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Harvard Bioscience based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Harvard Bioscience price pattern first instead of the macroeconomic environment surrounding Harvard Bioscience. By analyzing Harvard Bioscience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Harvard Bioscience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Harvard Bioscience specific price patterns or momentum indicators. Please read more on our technical analysis page.

Harvard Bioscience February 10, 2026 Technical Indicators

Most technical analysis of Harvard help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Harvard from various momentum indicators to cycle indicators. When you analyze Harvard charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Harvard Bioscience February 10, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Harvard stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.